Middle East and Africa Blood Collection Tubes for Liquid Biopsy Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (ccfDNA Tubes, cfRNA Tubes, CTC Tubes, gDNA Tubes, Intracellular RNA Tubes, and Others), Material (Glass and Plastic

Middle East and Africa Blood Collection Tubes for Liquid Biopsy Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (ccfDNA Tubes, cfRNA Tubes, CTC Tubes, gDNA Tubes, Intracellular RNA Tubes, and Others), Material (Glass and Plastic), Application (In-Vitro Diagnostics (IVD) and Research), and End User (Genetic Diagnostic Labs, R&D Centres, Conventional Diagnostic Centres, and Others)

The Middle East and Africa blood collection tubes for liquid biopsy market is expected to reach US$ 62.01 thousand by 2028 from US$ 22.99 thousand in 2021; it is estimated to grow at a CAGR of 15.2% from 2021-2028. The growth of the market is due to increasing prevalence of cancer worldwide and technological advancements in blood collection tubes for liquid biopsy. However, lack of skilled professionals leading to inaccurate blood collection tubes for liquid biopsy analysis is expected to restrict the market growth during the forecast period.

Liquid biopsy has revolutionized the way cancer disease states are detected and monitored. CTC tubes, intracellular RNA tubes, ccfDNA tubes, cfRNA tubes, gDNA tubes, and more advanced blood collecting tubes are available for liquid biopsy. The widely used circulating cell-free DNA (ccfDNA), cell-free RNAs (cfRNA), and the extracellular vehicles (EVs) / exosomes in which theseare kept are gaining a lot of attention in cancer diagnosis. For disease-specific EVs/exosomes or cfRNA analysis to be relevant, collected samples must preserve draw-time concentrations of these analytes.

Blood components such as platelets, red blood cells, and white blood cells become unstable when placed in a normal blood collection tube (BCT), thereby increasing EV and associated cfRNA levels. RNA Complete BCT is a direct blood collection tube that maintains concentrations of both cell-free RNA (cfRNA) and extracellular vesicles (EV) during collection time. The tube holds these two important segments at room temperature for up to 7 days, maximizing plasma yield and minimizing hemolysis during storage. This tube may be useful for anyone interested in EV or cell-free RNA research. Market players are introducing new technologically advanced products in the market. For instance, in November 2021, PreAnalytiX GmbH launched the QIAsymphony PAXgene Blood ccfDNA Kit (CE-IVD) to fulfill the new EU IVDR requirements. The QIAsymphony PAXgene Blood ccfDNA Kit and the PAXgene Blood ccfDNA Tube (CE-IVD) have been verified and validated as an integrated workflow solution for standardized and reproducible ccfDNA processing in diagnostic laboratories requiring automated solutions. Such technological advancements in blood collection tubes for liquid biopsy are emerging as trends.

Economic uncertainties and ongoing conflicts worsened the condition in the Middle East region. The COVID-19 pandemic caused turbulence to the economies of the Middle East.. The outbreak of COVID-19 reduced diagnostic services and screening programs, delaying the diagnosis of cancer due to restrictions imposed by the government. Cancer patients faced many challenges during the COVID-19 pandemic, such as susceptibility to serious infections and interruption of cancer or standard medical care. Increased pressure from increased hospitalization rates for COVID-19 patients led to reprofiling of many hospitals and departments, including oncology clinics, to treat COVID-19 patients. These factors are projected to hamper the growth of the Middle East and Africa blood collection tubes for liquid biopsy market.

The Middle East and Africa blood collection tubes for liquid biopsy market, based on product, has been classified into ccfDNA tubes, cfRNA tubes, CTC tubes, gDNA tubes, intracellular RNA tubes, and others. The ccfDNA segment held the largest share of the market in 2021 and is anticipated to register the highest CAGR during the forecast period.

The Middle East and Africa blood collection tubes for liquid biopsy market, based on material, is segmented into glass and plastic. In 2021, the plastic segment held a larger share of the market. However, the glass segment is expected to witness growth in demand at a faster CAGR from 2021 to 2028, owing to the rise in the detection and diagnosis of various medical conditions globally.

The Middle East and Africa blood collection tubes for liquid biopsy market, based on application, is segmented into In-vitro diagnostics (ivd), and research. In 2021, the In-Vitro diagnostics segment is likely to hold a larger share of the market. Moreover, the segment is expected to witness growth in demand at a faster CAGR from 2021 to 2028, owing to the rise in the detection and diagnosis of various medical conditions globally.

A few of the primary and secondary sources referred to while preparing the report on the Middle East and Africa blood collection tubes for liquid biopsy market are Saudi Ministry of Health (MOH), Cancer Association of South Africa (CANSA), and Gulf Co-operation Council (GCC).

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Middle East and Africa blood collection tubes for liquid biopsy market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the Middle East and Africa blood collection tubes for liquid biopsy market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.